ADR News Bulletin 2019 May (Volume 21 Number 1)
Healthcare professional
Industry member
Therapeutic Products
1 May 2019
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
Recall of three brands of losartan products found to contain N-Nitroso-N-Methyl-4-Aminobutyric Acid (NMBA)
Fluoroquinolones and risk of aortic aneurysm and dissection
Update on the recent study findings on the risk of non-melanoma skin cancer with prolonged use of hydrochlorothiazide
Analysis of adverse event reports for the year 2018
AE Case in Focus: Test Yourself
List of Dear Healthcare Professional Letters
Sodium-glucose cotransporter 2 (SGLT2) inhibitors and risk of necrotising fasciitis of the perineum (Fournier’s gangrene)
Click on the link below to download the issue in pdf:
ADR_News_May2019_Vol21_No1 [PDF, 655 KB]
